Next generation CAR-Treg therapies: an interview with Stéphane Boissel

​In this exclusive interview, Stéphane Boissel, TxCell, discusses recent data on TxCell's proprietary CAR-Treg cell therapies.

Go to the profile of RegMedNet
Jan 09, 2018
0
0
Upvote 0 Comment

In this interview, filmed exclusively at the Alliance for Regenerative Medicine's 5th Annual European Union Investor Day, Stéphane Boissel, CEO, TxCell, discusses recent data on TxCell's proprietary CAR-Treg cell therapies. 

Speaking to RegMedNet, Stéphane also discusses TxCell's preparations for clinical trial and commercial manufacture.

Read more about the Alliance for Regenerative Medicine on RegMedNet:
Go to the profile of RegMedNet

RegMedNet

eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.

No comments yet.